Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 9, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 22
- −2 vs. Q4 2021
- Portfolio value
- $529.0M
- −$349.5M (−39.8%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| FATEFate Therapeutics Inc | COM | 3,379,064 | $131.0M | 24.8% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,629,173 | $59.2M | 11.2% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $58.0M | 11.0% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,260,869 | $58.0M | 11.0% | −2,000,000−61.3% | Reduced | History |
| MGTXMeiraGTx Holdings plc | COM | 2,898,550 | $40.1M | 7.6% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $35.8M | 6.8% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 1,018,478 | $35.6M | 6.7% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $28.5M | 5.4% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $20.9M | 4.0% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $20.0M | 3.8% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $14.6M | 2.8% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $7.97M | 1.5% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $6.49M | 1.2% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $4.12M | 0.8% | 00.0% | Unchanged | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $2.25M | 0.4% | 00.0% | Unchanged | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 1,607,044 | $2.12M | 0.4% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 192,429 | $2.09M | 0.4% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $1.75M | 0.3% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $221.0K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $108.0K | <0.1% | 00.0% | Unchanged | History |
| CALCCalciMedica, Inc. | COM SHS | 49,547 | $61.0K | <0.1% | 00.0% | Unchanged | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $44.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2021 (2)
Positions held at the end of Q4 2021 that are gone from this filing.